Mohammad Mehdi Ranjbar

Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach

Zahra Molavi, Sara Razi, Seyed Amir Mirmotalebisohi et al. · Biomedicine & Pharmacotherapy · 2021 · 74 citations · Full text

Pharmacy, Bioinformatics, Pharmacology +17

Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains

Mona Shafaghi, Zohreh Bahadori, Hamid Madanchi et al. · BMC Bioinformatics · 2023 · 34 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Study on Analgesic and Anti-inflammatory Properties of Cordia myxa Fruit Hydro-alcoholic Extract

Mohammad Mehdi Ranjbar, Hossein Najafzadeh Varzi, Atefeh Sabbagh et al. · Pakistan Journal of Biological Sciences · 2013 · 27 citations

Medicine, Pharmacology, Experimental Pharmacology +15

Designing and Modeling of Multi-epitope Proteins for Diagnosis of Toxocara canis Infection

Maryam Ebrahimi, Seyyed Javad Seyyedtabaei, Mohammad Mehdi Ranjbar et al. · International Journal of Peptide Research and Therapeutics · 2019 · 24 citations

Life Sciences, Immunology, Infectious Diseases +13

Designing and Modeling of Complex DNA Vaccine Based on Tropomyosin Protein of Boophilus Genus Tick

Mohammad Mehdi Ranjbar, Shishir K. Gupta, Khodayar Ghorban et al. · Applied Biochemistry and Biotechnology · 2014 · 23 citations

Life Sciences, Immunology, Molecular Biology +14